Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL62919

ALTANSERIN
🧪 Phase II
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase II
O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1

Basic Information

ChEMBL ID CHEMBL62919
Name ALTANSERIN
Phase Phase II
Structure Type MOL
InChI Key SMYALUSCZJXWHG-UHFFFAOYSA-N

Known Names

Altanserin Altanserina Altanserine
8
Targets
12
Activities
1
Assay Types
0
PK Parameters
13
Publications
3
Known Names

Molecular Properties

411.5
MW (Da)
3.79
ALogP
5
HBA
1
HBD
58.1
PSA (Ų)
0.51
QED
0
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Achiral
USAN Stem -anserin
USAN Year 1984

Extended Properties

Molecular Formula C22H22FN3O2S
MW 411.50
Aromatic Rings 3
Heavy Atoms 29
NP-Likeness -1.56

Activity Summary

Ki 12 meas. best 9.89

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
5-hydroxytryptamine receptor 2A
CHEMBL224
Ki 9.89 9.705 0.1 2
5-hydroxytryptamine receptor 2A
CHEMBL322
Ki 9.89 9.5125 0.1 4
Unchecked
CHEMBL612545
Ki 8.34 8.34 4.5 1
Alpha-1A adrenergic receptor
CHEMBL319
Ki 8.3 8.3 5.0 1
5-hydroxytryptamine receptor 2C
CHEMBL225
Ki 7.4 7.4 40.0 1
D(2) dopamine receptor
CHEMBL217
Ki 7.21 7.21 62.0 1
D(2) dopamine receptor
CHEMBL339
Ki 7.21 7.21 62.0 1
5-hydroxytryptamine receptor 1A
CHEMBL214
Ki 5.8 5.8 1570.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
5-hydroxytryptamine receptor 2A Ki = 0.13 nM 9.89 Binding affinity to 5HT2A receptor 18187324
5-hydroxytryptamine receptor 2A Ki = 0.13 nM 9.89 Displacement of [3H]altanserine from rat cortical membrane 5HT2A receptor 19329329
5-hydroxytryptamine receptor 2A Ki = 0.13 nM 9.89 Displacement of [3H]-Ketanserin from rat frontal cortex 5-HT2A receptor 35939391
5-hydroxytryptamine receptor 2A Ki = 0.3 nM 9.52 Binding affinity against 5-hydroxytryptamine 2A receptor in humans 12014970
5-hydroxytryptamine receptor 2A Ki = 0.72 nM 9.14 Displacement of [3H]MDL from rat 5HT2A receptor expressed in GF62 cells by liqui... 19329329
5-hydroxytryptamine receptor 2A Ki = 0.74 nM 9.13 Displacement of [3H]MDL from rat 5HT2A receptor expressed in GF62 cells 18187324
Unchecked Ki = 4.55 nM 8.34 Binding affinity to alpha1 adrenergic receptor by competitive binding experiment 19329329
Alpha-1A adrenergic receptor Ki = 5.0 nM 8.3 Displacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptors 35939391
5-hydroxytryptamine receptor 2C Ki = 40.0 nM 7.4 Binding affinity to 5HT2C receptor by competitive binding experiment 19329329
D(2) dopamine receptor Ki = 62.0 nM 7.21 Binding affinity to dopamine D2 receptor by competitive binding experiment 19329329
D(2) dopamine receptor Ki = 62.0 nM 7.21 Displacement of [3H]-halopridol from rat striatum D2 receptors 35939391
5-hydroxytryptamine receptor 1A Ki = 1570.0 nM 5.8 Binding affinity to 5-HT1A receptor by competitive binding experiment 19329329

Literature References

PubMed DOI Target Context # Activities
18187324 10.1016/j.bmcl.2007.12.054 5-hydroxytryptamine receptor 2A 2
19329329 10.1016/j.bmc.2009.03.021 5-hydroxytryptamine receptor 2A 2
- 10.6019/CHEMBL4651402 SARS-CoV-2 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
12014970 10.1021/jm0200411 5-hydroxytryptamine receptor 2A 1
19329329 10.1016/j.bmc.2009.03.021 5-hydroxytryptamine receptor 1A 1
19329329 10.1016/j.bmc.2009.03.021 5-hydroxytryptamine receptor 2C 1
19329329 10.1016/j.bmc.2009.03.021 D(2) dopamine receptor 1
19329329 10.1016/j.bmc.2009.03.021 Unchecked 1
19329329 10.1016/j.bmc.2009.03.021 No relevant target 1
35939391 10.1021/acs.jmedchem.2c00633 5-hydroxytryptamine receptor 2A 1
35939391 10.1021/acs.jmedchem.2c00633 Alpha-1A adrenergic receptor 1
35939391 10.1021/acs.jmedchem.2c00633 D(2) dopamine receptor 1

Data from ChEMBL 36 via Core Engine